Large commercial plans and pharmacy benefit managers (PBMs) also offer plans with insulin OOPC limits and/or support value‐based designs with low or reduced OOPC for diabetes medications including insulin.6, 7. The gene discussed is INS; the disease is diabetes mellitus.